Japan Graves’ disease Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2025
Japan Graves’ disease market is growing at a CAGR of around 4.7% during the forecast period. According to the WHO, around 10.1% of the country’s population is suffering from diabetes, among which, the individuals suffering from type-1 diabetes are more prone to develop Grave’s disease in the near future. According to IDF, around 2.2 per thousand children and adolescents aged 14 years and below are suffering from type-1 diabetes in Japan. Thus, the prevalence of disease is likely to propel the Japan Graves’ disease market growth during the forecast period.
To Request a Sample of our Report on Japan
Graves’ disease Market: https://www.omrglobal.com/request-sample/japan-graves-disease-market
Further, the two regulatory
agencies responsible for the Grave’s disease treatment products and services in
Japan, includes, Ministry of Health Labor and Welfare (MHLW) and Pharmaceuticals
and Medical Devices Agency (PMDA) which are responsible for the laws and
regulation for medical devices & drugs and quality of pharmaceuticals and
medical devices respectively.
According to the National Centre
for Biotechnology Information (NCBI), in 2017, a range of childhood
hyperthyroidism cases are accredited under Grave’s disease. Moreover, pediatric
patients consist of less than 5% of the total number of patients that are
suffering from Grave’s disease, wherein the prevalence rate of the disease in
children and adolescents is around 0.02%. In Japan, around 40% of children have
a familial history of the Graves’ disease, with frequency rate of 2% to 3%.
Additionally, Japan Thyroid
Association is a Tokyo-based organization that consists of a range of scientists
that develop guidelines for the diagnosis and management of thyroid nodules.
The committee is further organized in the examination of the prevalence of
subclinical hypothyroidism in Japan. The organization has provided “Guidelines
for the Treatment of Grave’s Disease with Anti-thyroid Drug, in 2006”, stating
several standard therapeutic protocols to general physicians for the treatment
of Grave’s disease. Thus, such standard set by the government in Japan has
created scope for the Japan Graves’ disease market growth in the near future.
(Get 15% Discount on Buying this Report)
A
full Report Japan Graves’ disease Market is Available @ https://www.omrglobal.com/industry-reports/japan-graves-disease-market
Japan Graves’ disease Market Segmentation
By Diagnosis
·
Ultrasound
·
Imaging Tests
·
Radioactive Iodine Uptake
·
Blood Sample
By Treatment
·
Anti- Thyroid Medication
·
Radioactive Iodine Therapy
·
Surgery
Company Profiles
·
Abbott Laboratories Inc.
·
Allergan PLC
·
Eli Lilly and Co.
·
GlaxoSmithKline PLC
·
Johnson & Johnson
·
Macleods Pharmaceuticals Ltd.
·
Merck & Co. Inc.
·
Mylan NV
·
Novartis International AG
·
Pfizer Inc.
·
Sanofi SA
·
Takeda Pharmaceutical Co. Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment